# US 2026/0077140 A1 · Metered dose inhaler for ipratropium bromide solution

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0077140 A1
- Document ID: US20260077140A1
- Status: Published application
- Kind: A1
- Application number: 19/392,912
- Filed: 2025-11-18
- Published: 2026-03-19
- Earliest claimed: 2024-09-14
- Assignees: Glenmark Pharmaceuticals S.A.
- Applicants: Glenmark Pharmaceuticals Limited
- Inventors: Ulhas Dhuppad; Raveendra Pai; Michael Crick; Ashok Katkurwar; Jitendra Patil; Rakshit Trivedi; Ramakant Chanagare
- Web page: https://patentgrep.com/patent/US20260077140A1

## CPC

- A61M 15/0021: {Mouthpieces therefor}
- A61K 9/008: {comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]}
- A61K 31/439: the ring forming part of a bridged ring system, e.g. quinuclidine (8-azabicyclo [3.2.1] octanes A61K31/46)
- A61K 47/06: Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61M 15/009: {using medicine packages with incorporated spraying means, e.g. aerosol cans (pocket atomiser of the injector type A61M11/08)}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to a metered dose inhaler device comprising a stable inhalable composition of ipratropium bromide, contained in a canister fitted with a metering valve, an actuator and a dose indicator. The present invention also relates to a process for preparing such a pharmaceutical composition and its use in the treatment of respiratory disorders such as for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema in a subject in need thereof (e.g., a human).

## Claims

### Claim at position 1

1-21. (canceled)

### Claim 22

A metered dose inhaler comprising:
a canister containing an inhalable composition, the inhalable composition comprising ipratropium bromide; and
an actuator in fluid communication with the canister and configured to eject the inhalable composition in a spray pattern 6 cm away from the metered dose inhaler, the spray pattern having a mean area between 450 mm2 and 990 mm2, inclusive.

### Claim 23 (depends on 22)

The metered dose inhaler of claim 22, wherein:
the spray pattern is a second spray pattern and the metered dose inhaler is configured to eject the inhalable composition in a first spray pattern 3 cm away from the metered dose inhaler,
the first spray pattern and the second spray pattern each having a mean ovality ratio between 1.0 and 1.5, inclusive, and
the first spray pattern having a mean area between about 300 mm2 and about 690 mm2.

### Claim 24 (depends on 22)

The metered dose inhaler of claim 22, wherein the actuator defines a sump, and the sump has a sump volume of about 11.55 mm3 to about 22.25 mm3.

### Claim 25 (depends on 24)

The metered dose inhaler of claim 24, wherein the volume of the sump is about 12.1 mm3 to about 17.6 mm3.

### Claim 26 (depends on 24)

The metered dose inhaler of claim 24, wherein the sump volume of the sump is one of about 12.1 mm3, about 12.6 mm3, about 12.7 mm3, about 13.93 mm3, about 15.3 mm3, about 16 mm3, about 17.61 mm3, about 19.6 mm3, about 20.2 mm3, and about 21.86 mm3.

### Claim 27 (depends on 24)

The metered dose inhaler of claim 24, wherein:
the actuator further defines a metering valve stem receptacle,
the sump defines an opening facing the metering valve stem receptacle, and
a center of the opening is aligned with a center of the metering valve stem receptacle.

### Claim 28 (depends on 22)

The metered dose inhaler of claim 22, wherein the actuator defines a spray orifice having a spray orifice diameter of about 0.2 mm to about 0.5 mm.

### Claim 29 (depends on 22)

The metered dose inhaler of claim 22, wherein the actuator defines a jet having a jet length of about 0.25 mm to about 0.95 mm.

### Claim 30 (depends on 22)

The metered dose inhaler of claim 22, wherein the actuator defines a nozzle bore having a nozzle bore diameter that is about 0.2 mm to about 0.5 mm and a nozzle bore length that is about 0.25 mm to about 0.95 mm.

### Claim 31 (depends on 30)

The metered dose inhaler of claim 30, wherein the nozzle bore diameter is one of about 0.22 mm, about 0.25 mm, about 0.26 mm, about 0.28 mm, about 0.29 mm, and about 0.33 mm.

### Claim 32 (depends on 30)

The metered dose inhaler of claim 30, wherein the nozzle bore length is about 0.30 mm to about 0.95 mm.

### Claim 33 (depends on 30)

The metered dose inhaler of claim 30, wherein the nozzle bore length is one of about 0.31 mm, about 0.33 mm, about 0.35 mm, about 0.5 mm, and about 0.75 mm.

### Claim 34 (depends on 22)

The metered dose inhaler of claim 22, wherein the actuator defines a conical nozzle opening having a cone angle of about 70° to 110°.

### Claim 35 (depends on 22)

The metered dose inhaler of claim 22, wherein the cone angle is about 80° to 100°.

### Claim 36 (depends on 22)

The metered dose inhaler of claim 22, wherein the ipratropium bromide has a fine particle dose in a range of from about 3 μg to about 10 μg.

### Claim 37 (depends on 22)

The metered dose inhaler of claim 22, wherein the inhalable composition, when ejected from the metered dose inhaler, has a plume width of about 22 mm to 49 mm and plume angle of about 20° to 45°.

### Claim 38 (depends on 22)

The metered dose inhaler of claim 22, wherein the inhalable composition further comprises at least one of:
about 0.001% w/w to about 2.5% w/w of the ipratropium bromide;
about 0.001% w/w to about 1% w/w of citric acid;
about 1% w/w to 50% w/w of dehydrated alcohol; or
about 0.01% w/w to 5% w/w of water.

### Claim 39 (depends on 22)

The metered dose inhaler of claim 22, wherein the ipratropium bromide is ipratropium bromide monohydrate.

### Claim 40 (depends on 39)

The metered dose inhaler of claim 39, wherein the inhalable composition further comprises at least one of:
about 0.0375% w/w of the ipratropium bromide monohydrate;
about 0.004% w/w of citric acid;
about 15% w/w of dehydrated alcohol, (d) about 0.5% w/w of water, or
about 84.45% w/w of HFA-134a.

### Claim 41 (depends on 22)

The metered dose inhaler of claim 22, further comprising a metering valve fluidly connecting the canister to the actuator.
